Pulmonx financials
$1.98+1.02%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.8M | $20.6M | $22.6M | $21.5M | $23.9M | $22.5M | $23.8M | $20.4M | $20.8M | $18.9M | $19.3M | $17.7M |
| Gross profit | $17.7M | $16.0M | $17.5M | $16.1M | $17.2M | $16.3M | $17.6M | $15.0M | $15.3M | $14.1M | $14.4M | $13.0M |
| Gross margin | 78.0% | 77.9% | 77.6% | 74.7% | 72.1% | 72.5% | 74.0% | 73.7% | 73.7% | 74.7% | 74.7% | 73.7% |
| Operating income | -$9.1M | -$13.0M | -$9.9M | -$14.4M | -$14.8M | -$14.6M | -$13.4M | -$14.1M | -$15.6M | -$14.5M | -$13.9M | -$15.2M |
| Net income | -$10.1M | -$13.7M | -$10.4M | -$14.0M | -$15.2M | -$14.4M | -$13.2M | -$14.1M | -$15.3M | -$13.7M | -$13.9M | -$14.9M |
| Net margin | −44.3% | −66.3% | −46.1% | −64.9% | −63.6% | −64.1% | −55.4% | −69.4% | −73.7% | −72.9% | −72.0% | −84.3% |
| Diluted EPS | $-0.24 | $-0.33 | $-0.25 | $-0.34 | $-0.38 | $-0.36 | $-0.33 | $-0.36 | $-0.39 | $-0.36 | $-0.36 | $-0.39 |
| EBITDA | -$8.8M | -$12.7M | -$9.7M | -$14.1M | -$14.5M | -$14.3M | -$13.1M | -$13.8M | -$15.2M | -$14.1M | -$13.6M | -$14.8M |
| Operating cash flow | -$5.2M | -$10.1M | -$7.1M | -$8.2M | -$3.9M | -$13.2M | -$6.7M | -$7.2M | -$5.8M | -$11.8M | -$8.4M | -$8.6M |
| Free cash flow | -$5.2M | -$10.1M | -$7.1M | -$8.3M | -$4.0M | -$13.5M | -$6.8M | -$7.7M | -$6.2M | -$12.2M | -$8.6M | -$9.1M |
| Diluted shares | 42.5M | 41.9M | 41.4M | 40.9M | 40.4M | 40.0M | 39.6M | 39.3M | 38.9M | 38.6M | 38.4M | 38.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $55.8M | $61.6M | $69.8M | $76.5M | $75.5M | $74.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $8.8M | $14.1M |
| Total debt | $37.5M | $37.3M | $37.1M | $37.1M | $37.1M | $37.2M |
| Total assets | $114.7M | $120.0M | $129.3M | $138.3M | $147.2M | $150.7M |
| Total liabilities | $75.5M | $74.2M | $75.2M | $78.2M | $78.1M | $73.1M |
| Shareholders' equity | $39.2M | $45.8M | $54.1M | $60.0M | $69.1M | $77.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology